v3.26.1
SHAREHOLDERS' EQUITY
 6 Months Ended
Jun. 30, 2026
Equity [Abstract]  
SHAREHOLDERS' EQUITY SHAREHOLDERS' EQUITY
During the six months ended June 30, 2026, we repurchased 2.7 million shares of common stock for $120.0 million under our securities repurchase program. The Company had remaining repurchase authority of $300.4 million as of June 30, 2026.

During the six months ended June 30, 2026, we issued 0.9 million shares of common stock, net of shares withheld to pay tax withholdings, pursuant to employee benefit plans.

During the six months ended June 30, 2026, dividends declared on common stock totaled $33.5 million ($0.35 per common share). In May 2026, the Company increased its quarterly common stock dividend to $0.18 per share from $0.17 per share.

Accumulated other comprehensive loss, included in shareholders' equity as of June 30, 2026 and December 31, 2025, is comprised of the following (dollars in millions):
June 30,
2026		December 31,
2025
Net unrealized losses on investments having no allowance for credit losses (a)
$(791.5)$(661.6)
Unrealized losses on investments with an allowance for credit losses (1,254.5)(1,193.9)
Change in discount rates for liability for future policy benefits523.9 421.1 
Change in instrument-specific credit risk for market risk benefits0.8 0.9 
Deferred income tax assets338.5 318.5 
Accumulated other comprehensive loss$(1,182.8)$(1,115.0)
________________
(a)     The amortized cost and fair value of fixed maturity securities, available for sale, for which we have elected the fair value option were $8.5 million and $8.8 million, respectively, as of June 30, 2026. Accordingly, the net unrealized losses associated with these investments are excluded from accumulated other comprehensive loss. The amortized cost and fair value of fixed maturity securities, available for sale, for which we have elected the fair value option were $12.0 million and $13.0 million, respectively, as of December 31, 2025.